About 440,000 results
Open links in new tab
  1. Merck & Co., Inc. (MRK) - Yahoo Finance

    Find the latest Merck & Co., Inc. (MRK) stock quote, history, news and other vital information to help you with your stock trading and investing.

  2. MRK Stock Price | Merck & Co. Inc. Stock Quote (U.S.: NYSE ...

    3 days ago · Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and …

  3. Merck & Co Inc (MRK) Stock Price & News - Google Finance

    Get the latest Merck & Co Inc (MRK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  4. Investor relations - Merck.com

    4 days ago · Merck’s (NYSE: MRK) Q1 2025 results reflect strong progress, including increasing contributions from newer medicines and vaccines. Our company announced Q1 worldwide …

  5. MRK: Merck & Co Inc - Stock Price, Quote and News - CNBC

    Get Merck & Co Inc (MRK:NYSE) real-time stock quotes, news, price and financial information from CNBC.

  6. MRK Stock Price Quote | Morningstar

    4 days ago · See the latest Merck & Co Inc stock price (MRK:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

  7. Merck & Co. (MRK) Stock Price & Overview

    6 days ago · A detailed overview of Merck & Co., Inc. (MRK) stock, including real-time price, chart, key statistics, news, and more.

  8. MRK | Merck & Co. Inc. Stock Overview (U.S.: NYSE) | Barron's

    6 days ago · View real-time MRK stock price and news, along with industry-best analysis.

  9. Merck Stock (MRK) Rises as Top Wells Fargo Analyst Upgrades to …

    Merck (MRK) stock rose about 4% on Monday, as of writing, after top Wells Fargo analyst Mohit Bansal upgraded his rating for the pharma company to Buy from Hold. Bansal increased the …

  10. Merck (MRK) Surges 4.22% on Breakthrough Pipeline Momentum …

    2 days ago · adds antiviral pipeline depth, fueling investor optimism. Merck’s (MRK) explosive 4.22% rally on November 25, 2025, reflects a confluence of regulatory wins, strategic M&A, …